Cargando…
Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767926/ https://www.ncbi.nlm.nih.gov/pubmed/35148976 http://dx.doi.org/10.1016/j.clml.2022.01.010 |
| _version_ | 1784634814747377664 |
|---|---|
| author | Mohan, Meera Nagavally, Sneha Shah N, Nirav N Michaelis, Laura Chhabra, Saurabh Souza, Anita D Abedin, Sameem Runaas, Lyndsey Guru Murthy, Guru Subramanian Longo, Walter Hamadani, Mehdi Dhakal, Binod Hari, Parameswaran Fenske, Timothy S |
| author_facet | Mohan, Meera Nagavally, Sneha Shah N, Nirav N Michaelis, Laura Chhabra, Saurabh Souza, Anita D Abedin, Sameem Runaas, Lyndsey Guru Murthy, Guru Subramanian Longo, Walter Hamadani, Mehdi Dhakal, Binod Hari, Parameswaran Fenske, Timothy S |
| author_sort | Mohan, Meera |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8767926 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87679262022-01-19 Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies Mohan, Meera Nagavally, Sneha Shah N, Nirav N Michaelis, Laura Chhabra, Saurabh Souza, Anita D Abedin, Sameem Runaas, Lyndsey Guru Murthy, Guru Subramanian Longo, Walter Hamadani, Mehdi Dhakal, Binod Hari, Parameswaran Fenske, Timothy S Clin Lymphoma Myeloma Leuk Letter to the Editor Elsevier Inc. 2022-07 2022-01-19 /pmc/articles/PMC8767926/ /pubmed/35148976 http://dx.doi.org/10.1016/j.clml.2022.01.010 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Mohan, Meera Nagavally, Sneha Shah N, Nirav N Michaelis, Laura Chhabra, Saurabh Souza, Anita D Abedin, Sameem Runaas, Lyndsey Guru Murthy, Guru Subramanian Longo, Walter Hamadani, Mehdi Dhakal, Binod Hari, Parameswaran Fenske, Timothy S Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies |
| title | Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies |
| title_full | Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies |
| title_fullStr | Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies |
| title_full_unstemmed | Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies |
| title_short | Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies |
| title_sort | shorter interval between treatment and covid immunization is associated with poor seroconversion in patients with hematological malignancies |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767926/ https://www.ncbi.nlm.nih.gov/pubmed/35148976 http://dx.doi.org/10.1016/j.clml.2022.01.010 |
| work_keys_str_mv | AT mohanmeera shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT nagavallysneha shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT shahnniravn shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT michaelislaura shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT chhabrasaurabh shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT souzaanitad shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT abedinsameem shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT runaaslyndsey shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT gurumurthygurusubramanian shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT longowalter shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT hamadanimehdi shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT dhakalbinod shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT hariparameswaran shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies AT fensketimothys shorterintervalbetweentreatmentandcovidimmunizationisassociatedwithpoorseroconversioninpatientswithhematologicalmalignancies |